[ad_1]
(Reuters) – Medtronic (NYSE:) barely lifted the decrease finish of its annual revenue forecast on Tuesday, banking on sustained demand for its medical units and development from its new launches.
Medical system makers have been benefiting from elevated demand for non-urgent surgical procedures over the previous few quarters, as extra sufferers go for procedures deferred throughout the pandemic.
The corporate raised the decrease finish of its 2025 adjusted revenue forecast to $5.42 per share from $5.40 earlier, holding the higher finish at $5.50.
Analysts on common had been anticipating revenue of $5.44 for 2025, in response to LSEG information.
Medtronic posted adjusted revenue of $1.23 per share for the primary quarter, beating estimates of $1.20.
[ad_2]
Source link
